Back Issue


reports and analyses of the forces driving
science and technology investment in Canada

copyright 1999, Research Money Inc.

editor: Mark Henderson


Volume 12, Number 18, NOVEMBER 18, 1998

How it looks to me.... by Mark Henderson

FEATURE REPORTS | RESEARCH BRIEFS | PERSONALITIES

How it looks to me....
by Mark Henderson, editor, RE$EARCH MONEY Depending on who you talk to, the proposal for a Canadian Institutes of Health Research (CIHR) has the solid backing of the Health minister. Following the meeting of the CIHR task force and Allan Rock, work was accelerated on developing an appropriate governance structure and completing the business case analysis for the $500-million/year proposal.

Everyone agrees Rock was impressed -- he said so repeatedly. But opinion seems split over whether the minister should have offered the voluntary task force members some administrative assistance in preparing their case for Cabinet scrutiny.

Considering the magnitude of CIHR and its importance to the future well-being of every Canadian, CIHR deserves all the support it can get. If that means furnishing the task force with a few talented bodies to flesh out the vision, so be it. The economic and social benefits could go far towards achieving this government's top stated priority of raising the Canadian standard of living by improving its health care system.

Increase, focused, collaborative research is also certain to be welcomed by industry, which is always seeking the means to grab the upper hand in the face of intense global competition. The CIHR business case forcefully demonstrates how cutting-edge research can be transformed into profits as well as healthier Canadians. The talent is merely waiting to be properly harnessed.


Return to TOP OF PAGE | RE$EARCH MONEY INDEX



 

FEATURE REPORTS...

  AECL AND NRC JOIN FORCES TO PITCH $388-MILLION NEUTRON RESEARCH REACTOR FOR FUNDING IN NEXT BUDGET
  HARRIS CORP TEAMS WITH GOVERNMENT TO BOOST CANADIAN PRESENCE WITH NEW WORLD PRODUCT MANDATES
  CIHR TASK FORCE WORKING QUICKLY TO DEVELOP GOVERNANCE MODEL FOLLOWING KEY MEETING WITH HEALTH MINISTER
  BUSINESS CASE DEMONSTRATES MASSIVE SOCIAL
AND ECONOMIC BENEFITS OF CIHR IMPLEMENTATION
  PMAC-MRC HEALTH PROGRAM LIKELY TO BE RENEWED
AS MILESTONES OF FIRST FIVE YEARS APPEAR WITHIN REACH
  NRC LAUNCHES BIOINFORMATICS RESOURCE
TO SERVE NATIONAL RESEARCH COMMUNITY

Return to TOP OF PAGE | RE$EARCH MONEY INDEX



 

RESEARCH BRIEFS

  • Janssen to fund R&D for Allelix antipsychotic technology
  • Lumonics merges with GSI to create international powerhouse
  • IBM donates $1 million for high-performance computing research
  • Newcourt donates $3.75 million for financial services research
  • Gensel raising $1.2 million to advance sperm sexing technology
  • IBEX Technologies resumes Phase III trials for Nuetralase
  • Saskatchewan Nutraceutical Network officially launched
  • Saskatchewan government funds 32 ag-research projects


Return to TOP OF PAGE | RE$EARCH MONEY INDEX






 

Janssen to fund R&D for Allelix antipsychotic technology Allelix Biopharmaceuticals Inc has entered into a collaborative R&D agreement with Belgium's Janssen Pharma- ceutica NV to develop its glycine re-uptake inhibitor technology platform. The agreement, through Allelix's US subsidiary -- Allelix Neuroscience Inc -- will see Janssen make an upfront payment of $6.2 million, plus a $3.1 million fee, annual R&D payments and annual R&D funding in return for worldwide marketing rights. Allelix will also receive royalty payments from the sale of products resulting from the partnership, likely multiple antipsychotic medications for the treatment of schizophrenia. The agreement also involves Johnson & Johnson Development Corp, a unit of Janssen's parent firm which is a shareholder of Allelix common stock. R&D funding is slated for two years with an extension option....


Return to Research Briefs Index







 

Lumonics merges with GSI to create international powerhouse Lumonics Inc, Kanata ON is merging with General Scanning Inc, Watertown NY, to create one of the largest producers of advanced laser-based manufacturing systems in the world. The new firm -- to be called GSI Lumonics -- will have combined sales of US$300 million and sales in 40 countries. When the merger is completed early next year, Lumonics president/CEO Warren Scott Nix will become president/COO, while his GSI counterpart -- Charles Winston -- becomes the new firm's CEO....


Return to Research Briefs Index







 

IBM donates $1 million for high-performance computing research IBM Corp, Armonk NY, has made a $1-million donation to establish a high performance computing facility at Queen's Univ. Touted as the largest education grant ever awarded by IBM's education division in Canada, it was made to the High Performance Computing Virtual Laboratory (HPCVL) consortium comprised of Queen's, the Univ of Ottawa, Carleton Univ and the Royal Military College of Canada. The high computing expertise will be used in more than 100 projects at the partner institutions for research into astrophysics, information technology, drug development, communications, manufacturing, environment, finance, economics and policy studies. HPCVL is a member of C3.ca, a national association dedicated to improving Canada's high computing performance network....


Return to Research Briefs Index







 

Newcourt donates $3.75 million for financial services research Newcourt Credit Group is making a $3.75-million donation to three Toronto-based universities for research into the financial services sector. The donation was made through the 17-year-old Toronto Community Foundation, a full-service organization that creates donation strategies for corporations and individuals enabling donors to create philanthropic legacies. York Univ will receive $2 million through its Schulich School of Business to strengthen its teaching and research into the financial services sector. The Univ of Toronto receives $1.5 million to establish and endow a chair in structured finance at the Joseph L Rotman School of Management. Ryerson Polytechnic Univ receives $250,000 to permanently fund the Newcourt Ryerson Business Forum, focusing on current business issues....


Return to Research Briefs Index








  Gensel raising $1.2 million to advance sperm sexing technology Gensel Biotechnologies Ltd is raising $1.2 million by offering rights to purchase common shares for its shareholders, increasing its outstanding share by approximately five million. The funds will be used to fund ongoing R&D for its sperm sexing technology developed at the Univ of Guelph under contract from Gensel....


Return to Research Briefs Index








  IBEX Technologies resumes Phase III trials for Nuetralase IBEX Technologies Inc will resume Phase III trials of its drug Neutralase, after an earlier trial was suspended. The trial is intended to show the use of its therapeutic enzyme in treating bypass surgery patients. IBEX will test the drug at a higher dose based on results that showed patients using Neutralase experienced fewer drops in systemic blood pressure, but suffered from a higher incidence of bleeding. A new Phase III protocol will be submitted to the FDA by year's end....


Return to Research Briefs Index








  Saskatchewan Nutraceutical Network officially launched The Canada-Saskatchewan Agri-Food Innovation Fund has officially announced the awarding of $1 million to the Saskatchewan Nutraceutical Network (SNN). Operational and funded since last February, SNN will represent and promote the province's emerging nutraceutical sector, while acting as a clearing house for information. SNN is the first fully funded network in Canada, although other provinces have initiatives of varying size and scope. Earlier this year the Univ of Alberta launched a Functional Foods Centre of Excellence with $460,000 in federal funding. SNN has already signed up 35 members representing all sectors, and expects to add more in the near future. FMI: www.nutranet.org....


Return to Research Briefs Index








  Saskatchewan government funds 32 ag-research projects The Saskatchewan Agriculture Development Fund has awarded $3.1 million to 32 new projects covering a wide range of agriculture-related research. The Univ of Saskatchewan receives $1.8 million for 17 different projects; Six projects at Agriculture and AgriFood Canada receive nearly $600,000. The National Research Council's Plant Biotechnology Institute attracted $250,000 for two projects, while the Alberta Research Council and Alberta Environment received $140,000 for two projects....


Return to Research Briefs Index



Return to TOP OF PAGE | RE$EARCH MONEY INDEX





 

PERSONALITIES


Gedas Sakus has announced that he will step down as president of Nortel Networks Technology -- Canada's largest private-sector R&D enterprise and the amalgamated R&D operations of Northern Telecom Ltd and Bell-Northern Research. Sakus' role in engineering the re-organization capped a 36-year career with Nortel that began upon his graduation from the Univ of Toronto with a BSc in electrical engineering. Starting out as the first engineer hired for the firm's Bramalea switching plant. He has been president of both Bell-Northern Research and Nortel's Public Carrier Networks division. The 59-year-old Sakus holds a position with the Information Technology Association of Canada and is a member of the Advisory Council on Science & Technology, reporting to the prime minister. He was recently inducted into the Univ of Toronto's Engineering Alumni Hall of Distinction....

The Saskatchewan Research Council (SRC) has reached within its own executive ranks to choose Jim Hutchinson as its new president and CEO. Hutchinson began his new duties September 1. He replaces Ron Woodward, who accepted the position of president at Red Deer College. A 13-year SRC veteran, Hutchinson has held several executive positions, most recently as VP and COO. He will continue to help SRC provide applied science and technology infrastructure expertise to public and private partners....

Duncan MacIntyre has been appointed president and CEO of CME Telemetrix Inc, replacing company founder Aidan Furlong, who remains as vice chairman and director. MacIntyre has spent much of his career with Monsanto, holding various positions including VP and GM of Monsanto Canada Chemicals and VP international of its Chicago-based Nutrasweet subsidiary. He is the founding president and CEO of Canada's National Quality Institute. MacIntyre's immediate responsibility is to move CME's EMG products and non-invasive glucose monitor closer to commercialization....


RE$EARCH MONEY -- November 18, 1998
Return to TOP OF PAGE | RE$EARCH MONEY INDEX